Cargando…
Characterising the prognostic potential of HLA-DR during colorectal cancer development
HLA-DR, an MHC class II molecule that mediates antigen presentation, is a favourable prognostic indicator in colorectal cancer (CRC). However, the dynamics and location of HLA-DR expression during CRC development are unclear. We aimed to define HLA-DR expression by immunohistochemistry in colorectal...
Autores principales: | Dunne, Margaret R., Phelan, James J., Michielsen, Adriana J., Maguire, Aoife A., Dunne, Cara, Martin, Petra, Noonan, Sinead, Tosetto, Miriam, Geraghty, Robert, Fennelly, David, Sheahan, Kieran, Ryan, Elizabeth J., O’Sullivan, Jacintha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347515/ https://www.ncbi.nlm.nih.gov/pubmed/32306077 http://dx.doi.org/10.1007/s00262-020-02571-2 |
Ejemplares similares
-
Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
por: Noonan, Sinead A., et al.
Publicado: (2018) -
Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
por: Martin, Petra, et al.
Publicado: (2014) -
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients
por: Dunne, Margaret R., et al.
Publicado: (2017) -
Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
por: Murphy, Adrian G., et al.
Publicado: (2016) -
Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer
por: Michielsen, Adriana J., et al.
Publicado: (2011)